Načítá se...
AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy
BACKGROUND: Adiponectin (ApN) is a hormone known to exhibit insulin‐sensitizing, fat‐burning, and anti‐inflammatory properties in several tissues, including the skeletal muscle. Duchenne muscular dystrophy (DMD) is a devastating disease characterized by dystrophin deficiency with subsequent chronic...
Uloženo v:
| Vydáno v: | J Cachexia Sarcopenia Muscle |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7113498/ https://ncbi.nlm.nih.gov/pubmed/31965757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12531 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|